Join Now

Recursion Pharmaceuticals Named One of Utah’s 2018 Top Workplaces by The Salt Lake Tribune

November 6, 2018 in Public Policy by Blaire Wachter

SALT LAKE CITY, Nov. 5, 2018 /PRNewswire/ — Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover and develop drugs at scale, has been awarded a 2018 Top Workplaces award by The Salt Lake Tribune. The honor coincides with the official opening of Recursion’s expansive new research and development (R&D) facility in downtown Salt Lake City, which features a 70-foot climbing wall, chef-prepared lunches, and generous healthcare coverage.

“It’s an honor to receive the award and to cut the ribbon on our new facility on the same day,” said Chris Gibson, Ph.D., co-founder and CEO of Recursion. “We put a lot of effort into creating a positive, healthy, and creative environment for our team, but I think this award really reflects the sense of purpose and fulfillment that we all get unlocking biology to discover meaningful new therapies for patients in need.”

Founded in 2013, Recursion uses a combination of experimental biology, automation, and artificial intelligence/machine learning to test thousands of new hypotheses every day. Having outgrown its first two facilities in Research Park, the team has now graduated to a new location at The Gateway in downtown Salt Lake City. At more than 100,000 square feet, the new headquarters will allow the company to triple its experimental capacity as it accelerates towards its goal of discovering 100 new drugs by 2025.

“The leadership team at Recursion sets an important example, supporting their employees personally and practically, through top-tier facilities, benefits, and perks,” said Pam Jacobson, director of HTS Cell Culture Core at Recursion. “That in itself is great, but what I love most is that our mission attracts exceptionally talented people from tech, biotech, and pharma. Everyone I work with here is passionate and inspired, allowing us to forge entirely new paths to life-improving medical discoveries.”

“With a foot in both tech and biotech, Recursion needs to invest in talented people and state-of-the-art equipment and facilities,” said Zavain Dar, principal at Lux Capital and a member of Recursion’s board. “The Top Workplaces award is a byproduct of that investment and the company’s commitment to helping its people thrive by providing excellent facilities and benefits.”

The Top Workplaces list is based on anonymous employee feedback gathered through a third-party survey administered by research partner Energage, LLC (formerly WorkplaceDynamics). The survey measures several aspects of workplace culture, including alignment, execution, and connection.

About Energage, LLC
Headquartered in Exton, Pa., Energage (formerly known as WorkplaceDynamics) is a leading provider of technology-based employee engagement tools that help leaders to unlock potential, inspire performance, and achieve amazing results within their organizations. The research partner behind the Top Workplaces program, Energage has surveyed more than 47,000 organizations representing well over 16 million employees in the United States.

About Recursion

Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence methods in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease. Recursion applies causative perturbations to human cells to generate disease models and associated biological image data. Recursion’s rich, relatable database of more than a petabyte of biological images generated in-house on the company’s robotics platform enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics to radically improve lives. Recursion is headquartered in Salt Lake City. Learn more at www.recursionpharma.com, or connect on TwitterFacebook, and LinkedIn.

Recursion Media Contacts:

Kevin Lynch, Ph.D.
Recursion Pharmaceuticals
press@recursionpharma.com

Jessica Yingling, Ph.D.
Little Dog Communications
+1-858-344-8091
jessica@litldog.com

SOURCE Recursion Pharmaceuticals

Related Links

Home